The investment seeks long-term capital appreciation and current income... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFAX | 13.30 | 0.22 | +1.68% |
AlphaCentric Life Sciences & Hlthcare A | |||
VGPMX | 17.01 | 0.21 | +1.25% |
Vanguard Global Capital Cycles Investor | |||
JHUKX | 37.15 | 0.40 | +1.09% |
JPMorgan Emerging Markets Equity R4 | |||
CRCRX | 9.78 | 0.08 | +0.82% |
NYLI CBRE Real Estate Class C | |||
CMIDX | 22.44 | 0.16 | +0.72% |
Congress Mid Cap Growth Retail |
A.I.dvisor indicates that over the last year, ALVAX has been closely correlated with VIVAX. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALVAX jumps, then VIVAX could also see price increases.
Ticker / NAME | Correlation To ALVAX | 1D Price Change % | ||
---|---|---|---|---|
ALVAX | 100% | -0.29% | ||
VIVAX - ALVAX | 74% Closely correlated | -0.32% | ||
VIVIX - ALVAX | 74% Closely correlated | -0.32% | ||
VVIAX - ALVAX | 74% Closely correlated | -0.34% | ||
DODGX - ALVAX | 70% Closely correlated | -0.21% | ||
RMFEX - ALVAX | 44% Loosely correlated | +0.10% | ||
More |